Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Use of hematologic biomarkers during chemotherapy predicts survival in ovarian cancer patients.
Journal: European journal of gynaecological oncology
Published: January 01, 2017
The CD47 "don't eat me signal" is highly expressed in human ovarian cancer.
Journal: Gynecologic oncology
Published: March 18, 2016
Docetaxel and nab-paclitaxel are safe alternative options for patients with gynecologic malignancies following hypersensitivity reaction to paclitaxel.
Journal: European journal of gynaecological oncology
Published: January 01, 2016
Higher than expected frequencies of non-ovarian cancers within a large familial ovarian cancer registry.
Journal: American journal of clinical and experimental obstetrics and gynecology
Published: November 26, 2015
Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: August 15, 2015
Poorly differentiated Sertoli-Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report.
Journal: Gynecologic oncology reports
Published: May 15, 2015
Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator.
Journal: Gynecologic oncology reports
Published: July 20, 2014
Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer.
Journal: Gynecologic oncology
Published: February 20, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026